In addition, IL-1β is able to promote intestinal inflammatory damage by collaborating in the activation and differentiation of T cells that produce IL-17 or IFN-γ (54), which are increased and are highly active in the intestinal mucosa of IBD patients (1, 2). The gene discussed is IL17A; the disease is inflammatory bowel disease.